Metabolism and Nutrition Disorder Clinical Trial
Official title:
Association Between Serum Metabolism Markers and Biological Rhythm
The circadian regulation in mammals have been known for a long time. A special group of clock genes, organized in feedback loops, are responsible for the circadian regulation in both the SCN and peripheral organs. The central clock is mainly entrained by the light-dark cycle, while the peripheral ones in organs such as liver and intestine, are more influenced by the feeding-fasting cycles. The coordination of central and peripheral clocks is thought to be essential in the maintenance of physiological homeostasis.This study aim to investigate the association between biological rhythm and metabolism.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05864833 -
METabolism After Orthopedic Surgery
|
||
| Completed |
NCT02235961 -
Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT02918279 -
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
|
Phase 3 | |
| Completed |
NCT00978393 -
A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
|
Phase 1 | |
| Completed |
NCT03661879 -
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
|
Phase 1 | |
| Completed |
NCT05024032 -
A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
|
Phase 3 | |
| Completed |
NCT02568306 -
A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects
|
Phase 1 | |
| Completed |
NCT00781937 -
Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
|
Phase 3 | |
| Completed |
NCT03223493 -
Awareness, Care & Treatment in Obesity Management (ACTION) Study
|
||
| Completed |
NCT03308721 -
Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
|
Phase 1 | |
| Completed |
NCT02941042 -
A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.
|
Phase 1 | |
| Completed |
NCT02453711 -
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
|
Phase 2 | |
| Completed |
NCT02527200 -
Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
|
Phase 3 | |
| Completed |
NCT02958085 -
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
|
Phase 1 | |
| Terminated |
NCT00665665 -
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers
|
Phase 1 | |
| Completed |
NCT04156165 -
The Effect of High vs. Moderate Protein Consumption on Human Health
|
N/A | |
| Completed |
NCT02079870 -
Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo
|
Phase 1 | |
| Completed |
NCT03095807 -
Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity
|
Phase 1 | |
| Recruiting |
NCT05785221 -
Lifestyle Intervention on Metabolic Homeostasis
|
N/A | |
| Recruiting |
NCT06327854 -
NUtrition and ORal Health in Orthopaedic Surgery
|